CliffBio
small molecule

PROTONIX

PANTOPRAZOLE SODIUM

Loss of exclusivityDecember 2026latest FDA-listed patent expiry
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand namePROTONIX
Active ingredientPANTOPRAZOLE SODIUM
StrengthEQ 40MG BASE
Dosage formFOR SUSPENSION, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2007
Marketing statusRX

Listed patents

PatentExpiresType
7544370*PEDDecember 2026—
7544370June 2026product

More from Wyeth

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

PROTONIX patent cliff — loss of exclusivity December 2026 | CliffBio